华氏巨球蛋白血症

预约门诊

生存率

华氏巨球蛋白血症的生存率按风险分组判定。其他癌症可能按分期判定生存率，但分期并不适用于华氏巨球蛋白血症。医疗护理专业人员使用风险分组来描述这种癌症的严重程度。

为了确定风险分组，医疗护理团队会使用患者的年龄以及白蛋白和乳酸脱氢酶（LDH）这两项血液检测的结果。低危组患者的生存期往往更长，高危组患者死于华氏巨球蛋白血症的概率更高。

生存率是指该类癌症患者在确诊后一定年限仍然存活的百分比。举例来说，五年生存率是指确诊后五年仍然存活的患者百分比。

各风险分组的五年生存率估计值如下：

  • 低危组：约 93%。
  • 中低危组：约 82%。
  • 中危组：约 69%。
  • 高危组：约 55%。

请注意，生存率统计数据需要五年才能采集到。最新的生存率数据包含五年前接受过华氏巨球蛋白血症治疗的患者。这些患者可能未接受过最新疗法。

申请预约
诊断与治疗医生与科室
Dec. 20, 2025

Living with 华氏巨球蛋白血症?

Connect with others like you for support and answers to your questions in the Blood Cancers & Disorders support group on Mayo Clinic Connect, a patient community.

Blood Cancers & Disorders Discussions

shenriq
Essential Thrombocythemia: Looking for information and support

691 Replies Sat, Jul 18, 2026

Lori, Volunteer Mentor
My Bone Marrow Transplant (BMT/SCT) story: Will you share yours?

908 Replies Fri, Jul 17, 2026

lindagi
AML successful treatment

102 Replies Thu, Jul 16, 2026

See more discussions
  1. Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1475. Accessed Nov. 3, 2025.
  2. Epidemiology, pathogenesis, clinical manifestations, and diagnosis of Waldenstrom macroglobulinemia. https://www.uptodate.com/contents/search. Accessed Nov. 3, 2025.
  3. Clinical manifestations, pathologic features, and diagnosis of lymphoplasmacytic lymphoma. https://www.uptodate.com/contents/search. Accessed Nov. 3, 2025.
  4. Treatment and prognosis of Waldenstrom macroglobulinemia. https://www.uptodate.com/contents/search. Accessed Nov. 3, 2025.
  5. Elsevier Point of Care. Clinical Overview: Waldenstrom macroglobulinemia. https://www.clinicalkey.com. Accessed Nov. 3, 2025.
  6. Ferri FF. Waldenstrom macroglobulinemia. In: Ferri's Clinical Advisor 2026. Elsevier; 2026. https://www.clinicalkey.com. Accessed Nov. 3, 2025.
  7. Nimmagadda R. EPSi. Mayo Clinic. May 5, 2022.
  8. Elsevier Point of Care. Clinical Overview: Hyperviscosity syndrome. https://www.clinicalkey.com. Accessed Nov. 3, 2025.
  9. Prognosis in Waldenstrom's macroglobulinemia. International Waldenstrom's Macroglobulinemia Foundation. https://iwmf.com/prognosis. Accessed Nov. 13, 2025.

相关

相关医疗程序

产品与服务

华氏巨球蛋白血症